SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001538210-23-000025
Filing Date
2023-08-10
Accepted
2023-08-10 16:15:01
Documents
67
Period of Report
2023-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q nexi-20230630.htm   iXBRL 10-Q 760605
2 EX-31.1 nexi-20230630xexx311.htm EX-31.1 10135
3 EX-31.2 nexi-20230630xexx312.htm EX-31.2 10328
4 EX-32.1 nexi-20230630xexx321.htm EX-32.1 3993
5 EX-32.2 nexi-20230630xexx322.htm EX-32.2 4186
  Complete submission text file 0001538210-23-000025.txt   4525259

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT nexi-20230630.xsd EX-101.SCH 36487
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT nexi-20230630_cal.xml EX-101.CAL 43563
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT nexi-20230630_def.xml EX-101.DEF 143472
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT nexi-20230630_lab.xml EX-101.LAB 487315
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT nexi-20230630_pre.xml EX-101.PRE 298048
61 EXTRACTED XBRL INSTANCE DOCUMENT nexi-20230630_htm.xml XML 527096
Mailing Address 9119 GAITHER ROAD GAITHERSBURG MD 20878
Business Address 9119 GAITHER ROAD GAITHERSBURG MD 20878 301-825-9810
NexImmune, Inc. (Filer) CIK: 0001538210 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40045 | Film No.: 231159560
SIC: 2834 Pharmaceutical Preparations